Save up to 90% on Basaglar with Coupons, Discount Cards & Patient Assistance Programs

Basaglar is the brand name for insulin glargine and is available as a subcutaneous injection.

Basaglar is available as a KwikPen and Tempo Pen with a strength of 100 units/mL (U-100).

Basaglar is an insulin and is used to treat the following:

• Type 1 diabetes in adults and children
• Type 2 diabetes in adults

Basaglar is an insulin. Insulin is a hormone that lowers glucose (sugar) levels in the blood. It helps your body absorb and store sugar from your bloodstream and stops your liver from making glucose.

Basaglar is typically dosed as follows:

• Type 1 diabetes: The typical starting dose is 33% of your total daily insulin requirement injected under the skin once daily. Follow your provider’s instructions carefully. Basaglar should be used with a short-acting or rapid-acting, pre-meal insulin to meet the the remainder of your daily insulin requirements
• Type 2 diabetes: The typical starting dose is 0.2 units/kg or up to 10 units injected under the skin once daily

Basaglar is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you. You should not use this medication if you have symptoms of hypoglycemia (low blood sugar).

Common side effects of Basaglar:

• Infection
• Common cold
• Respiratory tract infection

Serious side effects are rare with Basaglar. Contact your healthcare provider immediately if you experience any of the following.

• Severe hypoglycemia (dangerously low blood sugar): if not treated, it can lead to unconsciousness, seizures, and even death
• Severe allergic reactions: problems breathing, blistering skin rash with a high fever, or if you feel your face, mouth, or throat swell up
• Low potassium levels: weakness, muscle cramps or twitches, digestive problems, abnormal heartbeats, kidney problems

The following medications may interact with Basaglar:

• Drugs that may increase the risk of hypoglycemia: antidiabeticagents, ACE inhibitors, angiotensin II receptor blocking agents disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors
• pentoxifylline, pramlintide, salicylates, somatostatin analog (e.g.octreotide), and sulfonamide antibiotics
• Drugs that may decrease the blood glucose lowering
• effect: atypical antipsychotics, corticosteroids, danazol, diuretics estrogens, glucagon, isoniazid, niacin, oral contraceptives phenothiazines, progestogens (e.g., in oral contraceptives)protease inhibitors, somatropin, sympathomimetic agents (e.g. albuterol, epinephrine, terbutaline), and thyroid hormones
• Drugs that may increase or decrease the blood glucose lowering effect: alcohol, beta-blockers, clonidine, lithium salts, and pentamidine
• Drugs that may blunt the signs and symptoms of
• hypoglycemia: beta-blockers, clonidine, guanethidine, and reserpine

Eli Lilly and Company

Published studies with use of insulin glargine products during pregnancy have not reported a clear association with
Basaglar and adverse developmental outcomes. You and your doctor will have to decide if you should take BASGLAR while you are pregnant or if you plan to become pregnant.

• Insulin Glargine